Ajit D’Souza

Executive Director, Drug Delivery & Devices DDCS Eli Lilly

Seminars

Thursday 3rd December 2026
Chaired by –
Thursday 3rd December 2026
Panel Discussion: Direct vs Systemic Delivery: Driving Pharma Buy-In, Bottlenecks & Patient Perception
3:00 pm
  • Compare direct CNS delivery and systemic administration in terms of tissue exposure and selectivity, and their impact on target-site concentration, dose, and efficacy–toxicity balance
  • Evaluate translational challenges for direct delivery relative to systemic modalities, including device integration and demonstration of tissue-level pharmacological advantage
  • Explore how patient, clinician, and commercial perspectives shape trade-offs between invasiveness and the potential for improved efficacy and reduced toxicity through targeted delivery
Eli Lilly company logo